Correlation Between Cingulate Warrants and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Lyra Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Lyra Therapeutics.
Diversification Opportunities for Cingulate Warrants and Lyra Therapeutics
0.26 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cingulate and Lyra is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Lyra Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 2.34 times more return on investment than Lyra Therapeutics. However, Cingulate Warrants is 2.34 times more volatile than Lyra Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 5.19 in Cingulate Warrants on August 28, 2024 and sell it today you would lose (0.46) from holding Cingulate Warrants or give up 8.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Cingulate Warrants vs. Lyra Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| Lyra Therapeutics |
Cingulate Warrants and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Lyra Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Cingulate Warrants vs. Cingulate | Cingulate Warrants vs. Celularity | Cingulate Warrants vs. NeuroSense Therapeutics Ltd |
| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |